Synairgen Plc Ord 1P is listed on the London Stock Exchange trading with ticker code SNG.L, and is part of the Medicine and Biotech Research sector. It has a market capitalisation of £1,028m, with approximately 91m shares in issue. Over the last year, Synairgen Plc share price has been traded in a range of 24.625, hitting a high of 31.50, and a low of 6.875.
Synairgen Plc, officially known as Synairgen Plc Ord 1P was formed in September of 2004, making the company thirteen years old. The company filed its latest accounts on 31st December 2014, showing a turnover of approximately 4.29 million GBX, and a pre-tax profit margin of 26.22%. Synairgen Plc currently has 8 directors, and has had 2 previous directors over the last 13 years. In the last set of accounts produced by Bdo Llp, the company showed 1.73 million paid in salaries to the 13 staff (average wage of 133 thousand), with the directors receiving an average 150 thousand each. In the accounts filed in 2014, the company paid 0 in dividends. These accounts also showed Synairgen Plc to have a net worth of 9.33 million, with 9.60 million held in cash.
Synairgen Plc is in the Medicine and Biotech Research sector.
Synairgen Plc is in the AIM 350 index.
|West African Minerals Corporation (WAFM.L)|
|Ixico Plc (IXI.L)|
|Synectics Plc (SNX.L)|
|Epistem Holdings Plc (EHP.L)|
|B.p. Marsh & Partners Plc (BPM.L)|
|Shares in Issue||91m|
|52 Week High||31.50|
|52 Week Low||6.875|